©  Balda  AG  

Welcome to Balda

Investor presentation August 2011

©  Balda  AG  

Contents

!   Balda Group •  Segments •  Customers •  Locations

!   Key Figures for the first six months of 2011 •  Group •  Segments

!   Forecast •  Group •  Segments

2

©  Balda  AG  

I. Balda Group

©  Balda  AG  

Medical segment !   Plastic solutions for pharmaceutical, diagnostic and medical

equipmentmarket segments with the focus on the personal health care market

!   Most promising segment of Balda

!   Alongside strong organic growth, Balda pursues strategic expansion

3 4

©  Balda  AG  

Electronic Products segment

!   Headsets, camera housings and tablet computers

!   The segment increased business volume substantially to 35.4million euros in 2020, operating profit negative

!   The segment took a big step forward in its planned strategic diversification with new products and new customers.

11 2 5

©  Balda  AG  

MobileCom segment !   Products: Components for mobile telephones, including

smartphones

!   The segment did not achieve its targets in terms of both sales and profits in 2010

!   Strong price pressure and intense competition continue

!   Joint venture partner sought; reported as "discontinued business division" as of the first half of 2011

10 2 6

©  Balda  AG  

Our customers (extract)

MobileCom Electronic Products Medical

7

©  Balda  AG  

Locations

USA Europe Asia

USA

Morrisville

Boston Germany Bad Oeynhausen

Beijing

Suzhou

China

Ipoh Malaysia

Production Engineering office Tool shop Sales office

8

©  Balda  AG  

II. Key figures

©  Balda  AG  

Key figures for the first six months of 2011 (I)

!   Stabilisation processes and search for joint venture partners initiated in the MobileCom segment, since prospects for a successful restructuring are increasingly negative

!   The MobileCom segment has been included in the discontinued business division since the semi-annual report for 2011

!   All in all, the performance of the Medical and Electronic Products segments was positive

10

©  Balda  AG  

Key figures for the first six months of 2011 (II) (Medical and Electronic Products)

!   The sales of the Group rose to 28.9 million euros (previous year: 28.1 million euros)

!   The EBIT increased to 1.1 million euros (previous year: 0.6 million euros)

!   EBT at 10.4 million euros (previous year: 8.9 million euros)

11

©  Balda  AG  

Medical segment First six months of 2011

! Sales amounting to 16.5 million euros (previous year: 13.1 million euros)

!   Positive EBIT of 1.3 million euros (previous year: 1.1 million euros)

! According to plan, the business picks up in the second half of the year

12

©  Balda  AG  

Electronic Products segment First six months of 2011

! Sales declined slightly to 12.5 million euros (previous year: 14.9 million euros)

!   EBIT at minus 1.5 million euros, a decline by 1.0 million euros compared to the first half of 2010

13

©  Balda  AG  

Employees, Group, first six months of 2011 (Medical and Electronic Products)

!   Balda Group employed 1,025 people as at the end of the first half of 2011 (previous year: 1,040)

!   The lower number of staff is attributable to the increase in efficiency in the Electronic Products segment, whereas Medical increased its number of employees slightly

!   MobileCom segment: 583 employees (as at end of December 2010: 1,344 employees)

14

©  Balda  AG  

Sound financial base (I)

!   The equity base rose substantially to 749.7 million euros (year-end 2009: 159.2 million euros)

!   The equity ratio in the Group rose due to high surplus and arevaluation of TPK shares to 92.5 percent (year-end 2009: 63.9 per cent)

!   Participation rights were converted in October 2010, and 4.7 million shares issued. This measure further strengthened the financial position of the Group

15

©  Balda  AG  

Sound financial base (II)

!   The operating cash flow rose substantially in the first half of 2011, to 7.7 million euros

!   Balda AG is almost entirely debt-free

!   The inventory of liquid funds stood at 36.4 million euros as at 30 June 2011

16

©  Balda  AG  

Asset position/Balance sheet structure First six months of 2011

!   The balance sheet total of Balda Group rose to 901.9 million euros as at 30 June 2011 (31 December 2010: 810.5 million euros)

!   Change in the revaluation of the TPK holding is reflected inthe balance sheet as well

!   With the loss of significant influence, TPK holding is no longerconsidered an associated company and is reported as afinancial holding at market value

17

©  Balda  AG  

TPK IPO in Taiwan in October 2010 (I)

!   Balda holds 16.1 percent in TPK, the inventor of transparentprojected-capacitive touch technology

!   The IPO of TPK in October 2010 set the enterprise value of the company above expectations

!   Balda intends to sell its shares in TPK by the end of 2011

!   If sold, the shareholders will participate in the proceeds by a dividend payout

18

©  Balda  AG  

TPK IPO in Taiwan in October 2010 (II)

!   The TPK holding, previously reported at book value ("at equity"), has been recorded as a financial instrument at market value since October 2010

!   The share of profits is no longer shown in the profit and loss account: only dividend payments and profit from a possible sale of TPK shares

!   High EBT in 2010 due to the one-off impact on profit through the revaluation of the TPK shares

19

©  Balda  AG  

Medical segment Acquisition plans

!   The strategic growth aimed for by an acquisition would substantially strengthen the segment and the Balda Group as a whole !   A final decision is expected to be made in the second half of 2011 !   Assuming a positive vote on the acquisition by the Boards, a definite expansion of business volume is possible by the end of 2011 !   An acquisition would not depend on possible disposal of the TPK shares, even though economic reasons speak for not excluding this option at the outset

20

©  Balda  AG  

III. Forecast

©  Balda  AG  

Balda Group forecast 2011

!   Balda Group (Medical and Electronic Products) expects a sales volume of 70 to 80 million euros and a slightly positive operating profit

22

©  Balda  AG  

Segments Forecast 2011 !   MobileCom: Search for joint venture partners is on

(August 2011)

!   Electronic Products: After sales doubled in 2010, there is a realistic chance that the segment, with new products and scaling effects, will reach break-even in the operative business

!   Balda Medical will achieve definite double-digit growth in sales figures in 2011 and a steadily improving operating profit (EBIT)

23

©  Balda  AG  

Balda in 2011

!   Solving the difficult situation in MobileCom segment

!   Balda will grow organically in the Medical and Electronic Products segments

!   With the successful acquisition in the Medical segment or a neighbouring sector, Balda can set the cornerstone for a future-oriented and profitable alignment of theGroup

24

©  Balda  AG  

Disclaimer

!   This presentation includes “forward-looking statements” which are based on the current expectations of the management of Balda. They are subject to risks and uncertainty because they relate to events and depend on circumstances that will occur in the future, such as, for example, developments in the mobile communications industry, changes in technology and the ability to timely and successfully develop new products and various other factors. Balda does not undertake any obligation to update publicly or revise forward- looking statements except to the extent legally required.

!   This presentation is not an offer of securities for sale or a solicitation of an offer to purchase securities in the United States or elsewhere. The shares in Balda AG (the "Shares") may not be offered or sold in the United States or to or for the account or benefit of U.S. persons (as such term is defined in Regulation S under the U.S. Securities Act of 1933, as amended (the "Securities Act")) unless registered under the Securities Act or pursuant to an exemption from such registration. The Shares have not been and will not be registered under the Securities Act.

25

©  Balda  AG  

Thank you for your interest!

Clas Röhl Investor Relations Phone: + 49 5734-922-2728 Fax: + 49 5734-922-2604 Mail: croehl@balda.de http://www.balda.de/